Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "ključne besede" (toxicity) .

1 - 5 / 5
Na začetekNa prejšnjo stran1Na naslednjo stranNa konec
1.
Treatment-related cardiovascular toxicity in long-term survivors of testicular cancer
Jasenka Gugić Kevo, Lorna Zadravec-Zaletel, Irena Oblak, 2017, pregledni znanstveni članek

Povzetek: Testicular cancer is the most common malignancy in young men. Considering increasing incidence, exceptionally high cure rate, as well as long life expectancy, assessment of long term toxicity in testicular cancer survivors is of great importance. In the last decades a major effort has been made in order to reduce toxicity of treatment, while maintaining its high effectiveness. Conclusions Actual knowledge on treatment toxicity is based on outdated treatment modalities. Hopefully, modern treatment modalities could reduce toxicity, but, there is no firm confirmation for that at the moment, as data dealing with late sequelae of modern treatment of testicular cancer are not available yet due to the short period of observation. The life-threatening cardiovascular toxicity in testicular cancer survivors is major complication of platinum-based chemotherapy, mediastinal radiotherapy and even subdiaphragmatic radiotherapy.
Ključne besede: testicular cancer, cardiovascular toxicity, long-term survivors
Objavljeno v DiRROS: 24.05.2024; Ogledov: 76; Prenosov: 32
.pdf Celotno besedilo (484,07 KB)

2.
Immunotoxin - a new treatment option in patients with relapsed and refractory Hodgkin lymphoma
Barbara Jezeršek Novaković, 2015, pregledni znanstveni članek

Povzetek: Background. Even though Hodgkin lymphoma is a highly curable disease, some of the patients have either a refractory disease or experience a relapse following a successful primary therapy. Durable responses and remissions in patients with relapsed or refractory disease may be achieved in approximately one-half with salvage chemotherapy followed by high dose chemotherapy (HDT) and autologous hematopoietic cell rescue (SCT). On the other hand, patients who relapse after HDT and autologous SCT or those who have failed at least two prior multi-agent chemotherapy regimens and are not candidates for HDT have limited treatment options. Conclusions. A new treatment option in this population is an immunotoxin Brentuximab vedotin composed of a CD30 directed antibody linked to the antitubulin agent monomethyl auristatin E. It has demonstrated a substantial effectiveness and an acceptable toxicity. In the pivotal study, the overall response rate was 75% with 34% of complete remissions. The median durations of response were 20.5 and 6.7 months for those with complete remission and all responding patients, respectively. The median overall survival was 40.5 months (3-years overall survival 54%) and the median progression-free survival 9.3 months. The most common non-hematologic toxicities were peripheral sensory neuropathy, nausea, and fatigue while the most common severe side effects were neutropenia, thrombocytopenia, anemia, and peripheral sensory neuropathy.
Ključne besede: immunotoxin, Hodgkin lymphoma, toxicity, new treatment option
Objavljeno v DiRROS: 22.04.2024; Ogledov: 381; Prenosov: 387
.pdf Celotno besedilo (520,10 KB)

3.
4.
5.
Stability and toxicity of selected chlorinated benzophenone-type UV filters in waters
Romina Žabar, Darko Dolenc, Polonca Trebše, Tatjana Tišler, Gorica Grbović, Jun Yao, Rensheng Zhuang, 2013, izvirni znanstveni članek

Povzetek: Stability and toxicity of selected chlorinated benzophenone-type UV filters in waters
Ključne besede: UV filter, photostability, chlorination, toxicity, Vibrio fischeri
Objavljeno v DiRROS: 16.03.2016; Ogledov: 3900; Prenosov: 512
URL Povezava na celotno besedilo

Iskanje izvedeno v 0.14 sek.
Na vrh